9-100099331-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014425.5(INVS):​c.-110T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.176 in 153,298 control chromosomes in the GnomAD database, including 3,521 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 3478 hom., cov: 31)
Exomes 𝑓: 0.26 ( 43 hom. )

Consequence

INVS
NM_014425.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.634

Publications

18 publications found
Variant links:
Genes affected
INVS (HGNC:17870): (inversin) This gene encodes a protein containing multiple ankyrin domains and two IQ calmodulin-binding domains. The encoded protein may function in renal tubular development and function, and in left-right axis determination. This protein interacts with nephrocystin and infers a connection between primary cilia function and left-right axis determination. A similar protein in mice interacts with calmodulin. Mutations in this gene have been associated with nephronophthisis type 2. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2012]
INVS Gene-Disease associations (from GenCC):
  • nephronophthisis 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 9-100099331-T-G is Benign according to our data. Variant chr9-100099331-T-G is described in ClinVar as Benign. ClinVar VariationId is 364220.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.625 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INVSNM_014425.5 linkc.-110T>G 5_prime_UTR_variant Exon 1 of 17 ENST00000262457.7 NP_055240.2
INVSNR_134606.2 linkn.89T>G non_coding_transcript_exon_variant Exon 1 of 17
INVSNM_001318381.2 linkc.-486T>G 5_prime_UTR_variant Exon 1 of 18 NP_001305310.1
INVSNM_001318382.2 linkc.-1099T>G 5_prime_UTR_variant Exon 1 of 17 NP_001305311.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INVSENST00000262457.7 linkc.-110T>G 5_prime_UTR_variant Exon 1 of 17 1 NM_014425.5 ENSP00000262457.2

Frequencies

GnomAD3 genomes
AF:
0.175
AC:
26656
AN:
151948
Hom.:
3477
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0529
Gnomad AMI
AF:
0.0780
Gnomad AMR
AF:
0.269
Gnomad ASJ
AF:
0.238
Gnomad EAS
AF:
0.642
Gnomad SAS
AF:
0.321
Gnomad FIN
AF:
0.215
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.180
GnomAD4 exome
AF:
0.262
AC:
323
AN:
1232
Hom.:
43
Cov.:
0
AF XY:
0.261
AC XY:
221
AN XY:
846
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
6
American (AMR)
AF:
0.500
AC:
6
AN:
12
Ashkenazi Jewish (ASJ)
AF:
0.375
AC:
3
AN:
8
East Asian (EAS)
AF:
1.00
AC:
4
AN:
4
South Asian (SAS)
AF:
0.313
AC:
217
AN:
694
European-Finnish (FIN)
AF:
0.500
AC:
5
AN:
10
Middle Eastern (MID)
AF:
0.167
AC:
1
AN:
6
European-Non Finnish (NFE)
AF:
0.170
AC:
77
AN:
452
Other (OTH)
AF:
0.250
AC:
10
AN:
40
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.175
AC:
26666
AN:
152066
Hom.:
3478
Cov.:
31
AF XY:
0.184
AC XY:
13655
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0528
AC:
2192
AN:
41522
American (AMR)
AF:
0.269
AC:
4118
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.238
AC:
826
AN:
3470
East Asian (EAS)
AF:
0.643
AC:
3290
AN:
5118
South Asian (SAS)
AF:
0.321
AC:
1547
AN:
4824
European-Finnish (FIN)
AF:
0.215
AC:
2275
AN:
10596
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.175
AC:
11897
AN:
67942
Other (OTH)
AF:
0.182
AC:
384
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1019
2037
3056
4074
5093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.182
Hom.:
8044
Bravo
AF:
0.178
Asia WGS
AF:
0.436
AC:
1509
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 634/2178=29.1%

Dec 29, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Kidney disorder Benign:1
Aug 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nephronophthisis Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Infantile nephronophthisis Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
13
DANN
Benign
0.80
PhyloP100
0.63
PromoterAI
-0.017
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7024375; hg19: chr9-102861613; API